Koch Kevin

Edgewise Therapeutics, Inc. · President and CEO

Koch Kevin is listed in public filings as director, officer: President and CEO. This Koch Kevin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Edgewise Therapeutics, Inc. (EWTX). Investors use Koch Kevin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$70k4.3k sharesSellMay 2, 2025$16.45--
Edgewise Therapeutics, Inc.EWTX$3.0k100 sharesSellMar 7, 2025$30.00--
Edgewise Therapeutics, Inc.EWTX$28k900 sharesSellFeb 6, 2025$31.13--
Edgewise Therapeutics, Inc.EWTX$259k8.6k sharesSellFeb 5, 2025$30.03--
Koch Kevin History Trades | 交易笔记